BFluid Special Precautions

Careful Administration (BFLUID Injection should be administered with care in the following patients: Patients with hepatic dysfunction. [Abnormalities in water and electrolyte metabolism may be exacerbated.]
Patients with renal dysfunction. [Since these patients have impaired water and electrolyte metabolism, the solution should be administered with care.]
Patients with cardiovascular dysfunction. [An increase in the circulating blood volume may cause a burden on the heart, resulting in the patient's clinical condition to deteriorate.]
Patients with acidosis. [The patient's clinical condition may deteriorate.]
Patients with diabetes mellitus. [Impaired uptake of glucose into the tissues may result in hyperglycemia, which may cause the patient's clinical condition to deteriorate.]
Patients with known hypersensitivity to drugs.
Important Precautions: BFLUID Injection contains 15 g of amino acids (2.35 g nitrogen) and 150 kcal (nonprotein calories) in 500 mL. However, daily caloric requirements cannot be met by administering this solution as the sole source of nutritional support. This solution should therefore be used only for short-term nutritional therapy.
When used as a nutritional supplement in patients in whom oral intake is inadequate, the solution should be administered based on an overall assessment of the patient's nutritional requirements and oral intake.
When this solution is used alone in postoperative patients, its use should be limited to 3-5 days and oral/enteral nutrition or other regimens should be instituted as soon as it is feasible to do so.
BFLUID Injection contains 0.96 mg of thiamin chloride hydrochloride (vitamin B₁) as a vitamin source in 500 mL. Additional vitamin B₁ or other vitamins should be administered, depending on the patient's condition.
Use only as directed by a physician.
Use in Children: The safety of this product in children has not been established (no clinical experience).
Use in the Elderly: Since elderly patients often have reduced physiological function and associated hepatic, renal, or cardiac dysfunction, it is advisable to take measures such as reducing the dose by decreasing the infusion rate under careful supervision.